Sign in
Taking people in United StatesNo phase

Hearing Aids and Health Education to Study Hearing Loss and Memory Decline

Compares hearing aids with health education in middle-aged adults with early hearing loss.

Key facts

Who runs it
Columbia University
Where
New York, United StatesSee the site
Trial code
Registry title
Early Age-Related Hearing Loss Investigation (EARHLI)
Status
Recruiting
People taking part
150 people, planned
Started
1 Aug 2024
Expected to end
31 Dec 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Hearing Intervention
  • Health Education Intervention
Record updated
12 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 55 to 75 with mild to moderate hearing loss and mild memory problems (amnestic mild cognitive impairment). They will get either a hearing intervention with hearing aids or a health education program.

Age
55 to 75 years
Sex
All sexes
Disease stage
Hearing loss that began in adulthood, mild to moderate (pure tone average 20 dB to 55 dB HL in the better hearing ear), that hearing aids can help (word recognition in quiet ≥ 60% in the better ear). Also amnestic mild cognitive impairment (MMSE2 score >23, CDR global score 0.5, low Logical Memory II score for years of education).
Earlier treatment
People who use hearing aids now, or used them regularly in the past 6 months, cannot join.

Main reasons for not taking part

  • Hearing loss from birth, from a known gene change, or starting before age 45
  • A previous dementia diagnosis
  • Disability in 2 or more activities of daily living
  • Not willing to wear hearing aids at least 8 hours a day
  • Medical reason not to use hearing aids, such as an actively draining ear

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Age 55-75 years of age
  • Adult-onset hearing loss of approximately mild to moderate in severity (4-frequency 0.5, 1, 2, 4 kHz pure tone average 20 dB to 55 dB HL in better hearing ear)
  • Aidable hearing loss, defined by word recognition score in quiet ≥ 60% in better hearing ear
  • Amnestic mild cognitive impairment (MCI) defined by Mini-Mental State Exam (MMSE2) score >23, Clinical Dementia Rating (CDR) global score equivalent = 0.5, and ADNI3 criteria of Logical Memory II score of ≤6 if 0-7 years of education, ≤9 if 8-15 years, and ≤11 if ≥16 years
  • Availability of a study partner (informant) for the administration of the cognitive screen and the ADCS-Activities of Daily Living-Prevention Instrument (ADCS-ADL-PI)
  • Community-dwelling
  • Fluent in English or Spanish
  • Availability of participant in area for study duration

Who cannot take part

  • Prior dementia diagnosis
  • Current or previous consistent hearing aid user (such as utilization of hearing aids within the past 6 months beyond brief trials)
  • Corrected vision impairment (worse than 20/63 on MNRead Acuity Chart in worse eye)
  • Self-reported congenital hearing loss, known genetic mutation-related hearing loss, or hearing loss onset before middle age (<45 years old)
  • Reported disability in ≥ 2 activities of daily living (ADLs)
  • Unwillingness to wear hearing aids regularly (≥8 hours/day)
  • Medical contraindications to the use of hearing aids (e.g., actively draining ear)
  • Untreatable conductive hearing loss with air-bone gap > 15 dB in two or more contiguous octave frequencies in both ears

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 55 and 75 years old?

Where in United States

  • Columbia University Medical CenterNew York, United StatesContact: Larry TapiaTaking people

About the trial

What the trial wants to find out

Early Age-Related Hearing Loss Investigation (EARHLI) is a single site study that will randomize late middle age adults to either a hearing intervention (including hearing aids) or a health education intervention. Participants will be followed for 1 year. This study will provide information on reducing cognitive decline in those at risk for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD).

The 2 groups in the trial

  • Hearing InterventionOther group

    Participants will receive 4 sessions across 8 weeks with a later booster session and hearing aid fitting. Each session will take \~75 minutes.

  • Health Education InterventionOther group

    Participants will receive a modified health education program on healthy aging. It will match the number and length of sessions as the hearing intervention, including compliance/phone checks. Participants will be on a waitlist to obtain hearing aids without fee at the end of their 12-month participation.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Early Age-Related Hearing Loss Investigation (EARHLI): A Randomized Controlled Trial to Assess the Mechanisms Linking Early Age-Related Hearing Loss and Alzheimer's Disease and Related Dementias
Plain-language title
Hearing Aids and Health Education to Study Hearing Loss and Memory DeclineGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06174038, who can take part
Publications
Record updated
12 August 2026